Tradename | Company | Number | Date | Products |
---|---|---|---|---|
CHOLINE C-11 | Mayo Clinic PET Radiochemistry Facility | N-203155 RX | 2012-09-12 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
choline c 11 | New Drug Application | 2024-12-17 |
Code | Description |
---|---|
A9515 | Choline c-11, diagnostic, per study dose up to 20 millicuries |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Prostatic neoplasms | D011471 | — | C61 | 4 | 4 | 1 | — | 11 | 19 |
Adenocarcinoma | D000230 | — | — | — | — | 1 | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hepatocellular carcinoma | D006528 | — | C22.0 | — | 1 | — | — | 1 | 2 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | 1 | — | — | 1 | 2 |
Hypersensitivity | D006967 | EFO_0003785 | T78.40 | — | 1 | — | — | — | 1 |
Carcinoma | D002277 | — | C80.0 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Recurrence | D012008 | — | — | 1 | — | — | — | 2 | 3 |
Esophageal neoplasms | D004938 | — | C15 | 1 | — | — | — | — | 1 |
Lymphangioleiomyomatosis | D018192 | — | J84.81 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hyperparathyroidism | D006961 | EFO_0008506 | E21.3 | — | — | — | — | 3 | 3 |
Primary hyperparathyroidism | D049950 | EFO_0008519 | E21.0 | — | — | — | — | 2 | 2 |
Adenoma | D000236 | — | — | — | — | — | — | 1 | 1 |
Brain neoplasms | D001932 | EFO_0003833 | C71 | — | — | — | — | 1 | 1 |
Glioma | D005910 | EFO_0000520 | — | — | — | — | — | 1 | 1 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | — | — | — | — | 1 | 1 |
Drug common name | Choline c-11 |
INN | _ |
Description | (11)C-choline chloride is a quaternary ammonium salt that is the chloride salt of (11)C-choline. An intravenous radioactive diagnostic agent used as a tracer during positron emission tomography scans to help detect sites of recurrent prostate cancer. It has a role as a radioactive tracer, a radioactive imaging agent and a diagnostic agent. It is a chloride salt, a quaternary ammonium salt and an (11)C-modified compound. It contains an (11)C-choline. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C[N+](C)([11CH3])CCO.[Cl-] |
PDB | — |
CAS-ID | 87591-54-6 |
RxCUI | — |
ChEMBL ID | CHEMBL2095207 |
ChEBI ID | 72321 |
PubChem CID | — |
DrugBank | — |
UNII ID | M4AS4XGD4Q (ChemIDplus, GSRS) |